UTICA, N.Y., March 14 /PRNewswire/ -- CONMED Corporation (Nasdaq: CNMD)
announced today that its subsidiary, Linvatec Corporation, a leader in
arthroscopy and powered surgical instruments, and Val Med, a company
specializing in surgical suite design, recently finalized a formal five-year
partnership to co-market their respective products as an integrated product
offering. The partnership will position the two organizations for a
leadership role in the Integrated OR market. The two companies will showcase
this week their advanced Integrated OR technology at the Association of
Perioperative Registered Nurses (AORN) conference in Dallas, Texas.
The combination of CONMED, Linvatec and Val Med products provides an
effective turnkey solution for customers who are looking for the latest in OR
technology integration. This combined product offering will improve OR
ergonomics and efficiencies, and provide patients with better surgical
outcomes. These improvements tend to enhance OR staff morale, simplify
training requirements and reduce employee turnover.
In addition, this high technology OR will allow hospitals and surgery
centers to create standard operating rooms that accommodate both endoscopic
and open surgical procedures for all surgical specialties. New products to be
showcased in the Integrated OR include: Linvatec endoscopic surgical
equipment, ConMed electrosurgical equipment, and Val Med flat screen video
monitors, video networking products, ceiling mounted service arms, surgical
lights*, and the Nurse's Assistant(TM)* -- an intuitive touch screen that
provides a single integrated user interface for control and setup of OR
procedures
Joseph J. Corasanti, President and Chief Operating Officer of CONMED
commented, "This partnership supports one of our major strategic
objectives -- integrating services and product solutions to increase operating
room productivity and decrease hospital costs. The power in this alliance is
our ability to provide turnkey solutions. Few companies in the medical device
market are providing such effective and diverse product offerings. CONMED is
now one of them."
The Integrated OR showcase will be featured this week at the AORN in
Dallas, Texas. Val Med's booth (Hall A, #537) will feature both CONMED and
Linvatec surgical products. In addition, Val Med will hold a press conference
from 8:30 to 9 a.m. on Wednesday, March 14, 2001, in the AORN Press room
(D-262, second floor) to discuss new ways of maximizing efficiency in the
operating room.
CONMED is a medical technology company specializing in instruments and
implants for arthroscopic sports medicine, and powered surgical equipment,
such as drills and saws, for orthopedic, ENT and neurosurgery. The company is
also a leading developer, manufacturer and supplier of advanced medical
devices, including electrosurgical systems, ECG electrodes for heart
monitoring, and minimally invasive surgical devices. Headquartered in Utica,
New York, the Company's 2,400 employees distribute its products worldwide from
eight manufacturing locations.
This press release contains forward-looking statements based on certain
assumptions and contingencies that involve risks and uncertainties. The
forward-looking statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995 and relate to the
Company's performance on a going-forward basis. The forward-looking
statements in this press release involve risks and uncertainties which
could cause actual results, performance or trends, including the above
mentioned anticipated revenues and earnings, to differ materially from those
expressed in the forward-looking statements. The Company believes that all
forward-looking statements made by it have a reasonable basis, but there can
be no assurance that management's expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or prove to be
correct. In addition to general industry and economic conditions, factors
that could cause actual results to differ materially from those discussed in
the forward-looking statements in this press release include, but are not
limited to: (i) the failure of any one or more of the assumptions stated above
to prove to be correct; (ii) the risks relating to forward-looking statements
discussed in the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 1999; (iii) cyclical purchasing patterns from customers,
end-users and dealers; (iv) timely release of new products, and acceptance of
such new products by the market; (v) the introduction of new products by
competitors and other competitive responses; and/or (vi) the Company's ability
to devise and execute strategies to respond to market conditions.
* 510K Pending. These products will not be sold in the United States
until 510K clearance is obtained.
SOURCE CONMED Corporation
 back to top
Related links:
http://www.conmed.com
Company News On-Call:
http://www.prnewswire.com/comp/201850.html or fax,
800-758-5804, ext. 201850
CONTACT:
Robert D. Shallish, Jr., Chief Financial
Officer of CONMED Corporation, 315-797-8375; or Investors -
Theresa Vogt or Sarah Torres; or Media - Stacey Nield or Dan
Budwick, all of Morgen-Walke Associates for CONMED Corporation,
212-850-5600
|
